282 related articles for article (PubMed ID: 16249336)
21. Equilibrium and transient state spectrophotometric studies of the mechanism of reduction of the flavoprotein domain of P450BM-3.
Sevrioukova I; Shaffer C; Ballou DP; Peterson JA
Biochemistry; 1996 Jun; 35(22):7058-68. PubMed ID: 8679531
[TBL] [Abstract][Full Text] [Related]
22. Electron transfer in human methionine synthase reductase studied by stopped-flow spectrophotometry.
Wolthers KR; Scrutton NS
Biochemistry; 2004 Jan; 43(2):490-500. PubMed ID: 14717604
[TBL] [Abstract][Full Text] [Related]
23. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
Roitel O; Scrutton NS; Munro AW
Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
[TBL] [Abstract][Full Text] [Related]
24. Proximal FAD histidine residue influences interflavin electron transfer in cytochrome P450 reductase and methionine synthase reductase.
Meints CE; Parke SM; Wolthers KR
Arch Biochem Biophys; 2014 Apr; 547():18-26. PubMed ID: 24589657
[TBL] [Abstract][Full Text] [Related]
25. Characterization of C415 mutants of neuronal nitric oxide synthase.
Richards MK; Clague MJ; Marletta MA
Biochemistry; 1996 Jun; 35(24):7772-80. PubMed ID: 8672477
[TBL] [Abstract][Full Text] [Related]
26. The flavoprotein component of the Escherichia coli sulfite reductase: expression, purification, and spectral and catalytic properties of a monomeric form containing both the flavin adenine dinucleotide and the flavin mononucleotide cofactors.
Zeghouf M; Fontecave M; Macherel D; Covès J
Biochemistry; 1998 Apr; 37(17):6114-23. PubMed ID: 9558350
[TBL] [Abstract][Full Text] [Related]
27. Control of electron transfer and catalysis in neuronal nitric-oxide synthase (nNOS) by a hinge connecting its FMN and FAD-NADPH domains.
Haque MM; Fadlalla MA; Aulak KS; Ghosh A; Durra D; Stuehr DJ
J Biol Chem; 2012 Aug; 287(36):30105-16. PubMed ID: 22722929
[TBL] [Abstract][Full Text] [Related]
28. Stopped-flow kinetic studies of flavin reduction in human cytochrome P450 reductase and its component domains.
Gutierrez A; Lian LY; Wolf CR; Scrutton NS; Roberts GC
Biochemistry; 2001 Feb; 40(7):1964-75. PubMed ID: 11329263
[TBL] [Abstract][Full Text] [Related]
29. Conformational changes of NADPH-cytochrome P450 oxidoreductase are essential for catalysis and cofactor binding.
Xia C; Hamdane D; Shen AL; Choi V; Kasper CB; Pearl NM; Zhang H; Im SC; Waskell L; Kim JJ
J Biol Chem; 2011 May; 286(18):16246-60. PubMed ID: 21345800
[TBL] [Abstract][Full Text] [Related]
30. Quantitation of FAD-dependent cytochrome P450 reductase activity by photoreduction.
Hodgson AV; Strobel HW
Anal Biochem; 1996 Dec; 243(1):154-7. PubMed ID: 8954538
[TBL] [Abstract][Full Text] [Related]
31. Three-dimensional structure of NADPH-cytochrome P450 reductase: prototype for FMN- and FAD-containing enzymes.
Wang M; Roberts DL; Paschke R; Shea TM; Masters BS; Kim JJ
Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8411-6. PubMed ID: 9237990
[TBL] [Abstract][Full Text] [Related]
32. [Nitric oxide synthase, typical flavohemoproteins and their complicated enzymology].
Jáchymová M; Masters BS; Horký K; Zima T; Martásek P
Cas Lek Cesk; 2006; 145(7):526-31. PubMed ID: 16921779
[TBL] [Abstract][Full Text] [Related]
33. A 31P-nuclear-magnetic-resonance study of NADPH-cytochrome-P-450 reductase and of the Azotobacter flavodoxin/ferredoxin-NADP+ reductase complex.
Bonants PJ; Müller F; Vervoort J; Edmondson DE
Eur J Biochem; 1990 Jul; 190(3):531-7. PubMed ID: 2115440
[TBL] [Abstract][Full Text] [Related]
34. Determination of the redox properties of human NADPH-cytochrome P450 reductase.
Munro AW; Noble MA; Robledo L; Daff SN; Chapman SK
Biochemistry; 2001 Feb; 40(7):1956-63. PubMed ID: 11329262
[TBL] [Abstract][Full Text] [Related]
35. Electron transfer by human wild-type and A287P mutant P450 oxidoreductase assessed by transient kinetics: functional basis of P450 oxidoreductase deficiency.
Jin Y; Chen M; Penning TM; Miller WL
Biochem J; 2015 May; 468(1):25-31. PubMed ID: 25728647
[TBL] [Abstract][Full Text] [Related]
36. Structure and function of NADPH-cytochrome P450 reductase and nitric oxide synthase reductase domain.
Iyanagi T
Biochem Biophys Res Commun; 2005 Dec; 338(1):520-8. PubMed ID: 16125667
[TBL] [Abstract][Full Text] [Related]
37. Potentiometric and further kinetic characterization of the flavin-binding domain of Saccharomyces cerevisiae flavocytochrome b2. Inhibition by anions binding in the active site.
Cénas N; Lê KH; Terrier M; Lederer F
Biochemistry; 2007 Apr; 46(15):4661-70. PubMed ID: 17373777
[TBL] [Abstract][Full Text] [Related]
38. A conserved flavin-shielding residue regulates NO synthase electron transfer and nicotinamide coenzyme specificity.
Adak S; Sharma M; Meade AL; Stuehr DJ
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13516-21. PubMed ID: 12359874
[TBL] [Abstract][Full Text] [Related]
39. A conserved aspartate (Asp-1393) regulates NADPH reduction of neuronal nitric-oxide synthase: implications for catalysis.
Panda K; Adak S; Konas D; Sharma M; Stuehr DJ
J Biol Chem; 2004 Apr; 279(18):18323-33. PubMed ID: 14966111
[TBL] [Abstract][Full Text] [Related]
40. Role of Asp1393 in catalysis, flavin reduction, NADP(H) binding, FAD thermodynamics, and regulation of the nNOS flavoprotein.
Konas DW; Takaya N; Sharma M; Stuehr DJ
Biochemistry; 2006 Oct; 45(41):12596-609. PubMed ID: 17029414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
